A Smart Self‐Immobilization Magnetic Resonance Contrast Agent for Delayed Tumor Imaging In Vivo
Angewandte Chemie International Edition · 22.12.2025 · 64 (52)
DOI: 10.1002/anie.202516998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 29.10.2025. Verfasst von Zheng Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Cen…. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Contrast Media, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Joint Funds for the innovation of science and Technology in Fujian province.
Abstract (Originalsprache)
Achieving tumor‐specific accumulation and high relaxivity remains critical yet challenging for improving magnetic resonance imaging (MRI) probe sensitivity. Here, we present P‐QM‐Gd , an enzyme‐responsive, self‐immobilizing small‐molecule MRI probe designed for high‐sensitivity tumor imaging. Upon activation by membrane‐bound alkaline phosphatase (ALP), P‐QM‐Gd is enzymatically converted to generate reactive quinone methide intermediates. These intermediates readily undergo nucleophilic addition with proximal protein residues, enabling the covalent conjugation of paramagnetic gadolinium complexes directly onto tumor cell membranes. This enzymatic self‐immobilization markedly increased the longitudinal relaxivity ( r 1 ) from 7.35 to 13.15 mM −1 s −1 (0.5 T, 21.3 MHz, 32 °C) and effectively “traps” the probe at the tumor site. P‐QM‐Gd showed rapid tumor uptake and efficient covalent labeling, achieving distinct MR contrast enhancement (> 60%). The imaging window was extended for up to 24 h in subcutaneous HeLa and orthotopic K7M2 tumor models. Notably, delayed MRI with P‐QM‐Gd enabled precision visualization of ∼1.3 mm orthotopic K7M2 tumors in mice. By overcoming the rapid washout and low sensitivity inherent to traditional small‐molecule MRI probes through this enzymatic self‐immobilization strategy, P‐QM‐Gd offers a promising approach for high‐sensitivity, high‐spatial resolution delayed tumor MRI, making it particularly effective for early‐stage lesion detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC) Nanjing University, Nanjing, 210023, China.
- Department of Traditional Chinese Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, 350001, China.
ORCID-Profile: Deju Ye
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Joint Funds for the innovation of science and Technology in Fujian province
Zitieren
APA
Huang, Z., Miao, Y., Lu, C., Luo, J., Zhang, Y., & Ye, D. (2025). A Smart Self‐Immobilization Magnetic Resonance Contrast Agent for Delayed Tumor Imaging In Vivo. Angewandte Chemie International Edition, 64(52). https://doi.org/10.1002/anie.202516998
Vancouver
Huang Z, Miao Y, Lu C, Luo J, Zhang Y, Ye D. A Smart Self‐Immobilization Magnetic Resonance Contrast Agent for Delayed Tumor Imaging In Vivo. Angewandte Chemie International Edition. 2025;64(52). doi:10.1002/anie.202516998
BibTeX
@article{Huang2025,
author = {Huang, Zheng and Miao, Yinxing and Lu, Chunmei and Luo, Jiewei and Zhang, Yan and Ye, Deju},
title = {A Smart Self‐Immobilization Magnetic Resonance Contrast Agent for Delayed Tumor Imaging In Vivo},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {52},
doi = {10.1002/anie.202516998}
}
EUVIMED